Disruption of tumor-intrinsic PGAM5 increases anti-PD-1 efficacy through the CCL2 signaling pathway.
Wei X, Wang H, Liu H, Wang J, Zhou P, Li X, He Y, Li Y, Han D, Mei T, Wang Y, Li Z, Ning J, Xu Z, Wang A, Li Y, Cheng J, Qian D.
Wei X, et al.
J Immunother Cancer. 2025 Jan 7;13(1):e009993. doi: 10.1136/jitc-2024-009993.
J Immunother Cancer. 2025.
PMID: 39773565